your market intelligence analyst
Search Results
149 results
Your search is now limited to «Clinical Trials» expert search.
GlobeNewswire 11/18/2019 01:30
Positive results from the Dolomites Phase 2 clinical trial in patients with open‑angle glaucoma or ocular hypertension demonstrated statistical superiority of NCX 470 0.065% over the current standard of care, latanoprost 0.005.
More from GlobeNewswire:
World Pharma News 11/17/2019 19:00
While there is strong evidence demonstrating the efficacy of PCSK9 inhibitors from various randomized clinical trial studies, there is less information on the effectiveness of these medicines on cardiovascular outcomes in real-world practice.
More from World Pharma News:
Business Wire 11/17/2019 10:45
These new analyses from the DAPA-HF trial reinforce the science behind FARXIGA as clinically significant across heart failure patient populations and suggest the potential to improve the current standard of care for millions of these patients.
More from Business Wire:
Benzinga 11/17/2019 08:42
Biotech stocks went about a consolidation move last week, although a few swung wildly in either direction in reaction to some catalytic events. Aslan (NASDAQ: ) after its late-stage biliary tract cancer drug candidate flunked a pivotal study. Lipocine Inc's (NASDAQ: ) investigational male sex hormone replacement therapy to win FDA nod, with the regulatory body shooting down the application for the third time. Now, here are the key catalytic events for the unfolding week. Conferences. American Heart Association, or AHA, Scientific Sessions 2019 – Nov. 16-18 in Philadelphia, Pennsylvania. 18th International Conference on Gastroenterology and Digestive Disorders – Nov. 18-19 in Abu Dhabi, UAE. 11th International Chronic Obstructive Pulmonary Dise.
More from Benzinga:
Pulmonary Hypertension News 11/13/2019 13:00
The vasodilator INOpulse increased physical activity and helped maintain higher levels of exercise in people with pulmonary hypertension (PH) associated with pulmonary fibrosis (PH-PF), preliminary results from a Phase 2 trial show.
More from Pulmonary Hypertension News:
PR Newswire 11/13/2019 07:00
Milestone plans to initiate a Phase 2 clinical trial in atrial fibrillation, another rapid heart rate condition, and expects to subsequently initiate an additional Phase 2 clinical trial in angina to establish proof-of-concept for the broader use of etripamil.
More from PR Newswire:
The sixth phase III trial will comprise of participants both with and without type 2 diabetes.
More from Pharmaceutical Business Review:
FierceBiotech 11/11/2019 17:25
Lipid-based Formulations for Early Stage Clinical Trials Liquid-filled capsule technology has a proven record for addressing complex API formulation challenges, but also offers a simple and effective pathway to the clinic.
More from FierceBiotech: 11/08/2019 10:23
Also, Researchers can use the following link http://trials.boehringeringelheim.
More from
Acasti may need to conduct at least one additional clinical trial to support FDA approval of a supplemental New Drug Application to expand CaPre's indications to this segment.
More from Middle East North Africa Financial Network (MENAFN):
BioNewsFeeds 11/04/2019 13:30
Treatment with Letairis (ambrisentan) failed to significantly reduce pulmonary blood pressure at rest and during exercise compared with a placebo in people with scleroderma and mild pulmonary hypertension (PH), a Phase 2 trial showed.
More from BioNewsFeeds:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications